ArticleWorld journal of clinical oncology2021

Lenvatinib-induced multiorgan adverse events in Hurthle cell thyroid cancer: A case report.

Muhammad Imran Butt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.